Zobrazeno 1 - 10
of 293
pro vyhledávání: '"23-valent pneumococcal polysaccharide vaccine"'
Autor:
Xiang Guo, Juan Li, Jing Qiu, Rui Zhang, Jia Ren, Zhuoying Huang, Zhi Li, Xiufang Liang, Fang Lan, Juan Chen, Fang Huang, Xiaodong Sun
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 237-245 (2024)
ABSTRACTBackground Pneumococcal vaccines are effective in preventing pneumococcal diseases in adults. The evaluation of the antibodies persistence to the 23-valent pneumococcal polysaccharide vaccine (PPV23) could provide evidence on PPV23 revaccinat
Externí odkaz:
https://doaj.org/article/e3d517bfcb434318bc1f8acd2e29411e
Autor:
Tao LI, Jianwen SUN, Xi LU, Haiyang XU, Yuhui JIN, Limin GONG, Yuhui CHENG, Jiangshun WAN, Liangliang JIANG, Jing LUO, Yanwei ZHAO, Binbing WANG
Publikováno v:
Zhongguo gonggong weisheng, Vol 40, Iss 7, Pp 809-816 (2024)
ObjectiveTo evaluate the safety of co-vaccination with domestic 23-valent pneumococcal polysaccharide vaccine (PPSV23) and split influenza virus vaccine (sFlu) in key populations aged 3 years and older and to provide a reference for formulating co-va
Externí odkaz:
https://doaj.org/article/c7aee2991bf94fa0bf933fd5a857f3e2
Autor:
Katrine Finderup Nielsen, Lise Birk Nielsen, Tine Dalby, Frederikke Kristensen Lomholt, Hans-Christian Slotved, Kurt Fuursted, Zitta Barrella Harboe, Charlotte Sværke Jørgensen, Palle Valentiner-Branth
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 6, Pp 1164-1172 (2024)
As a follow-up to a previous study, we investigated vaccine effectiveness (VE) of 23-valent pneumococcal polysaccharide vaccine (PPSV23) against invasive pneumococcal disease (IPD) among 1,254,498 persons >65 years of age as part of a vaccination pro
Externí odkaz:
https://doaj.org/article/6191ef7c64204b14bc999c31c1b1e71b
Autor:
Shuang Bai, Shanshan Zhou, Junnan Zhang, Weixin Chen, Min Lv, Jian Wang, Ao Zhang, Jiang Wu, Wei Zhao
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundConcomitant administration of COVID-19, influenza, and pneumococcal vaccines could reduce the burden on healthcare systems. However, the immunogenicity and safety of various combinations of a third booster dose of SARS-CoV-2 inactivated vac
Externí odkaz:
https://doaj.org/article/0131df7e610f42f8b1fc8bb700b17b87
Publikováno v:
Zhongguo gonggong weisheng, Vol 40, Iss 2, Pp 143-151 (2024)
ObjectiveTo examine the prevalence of 23-valent pneumococcal polysaccharide vaccine (PPV23) vaccination and its associates among elderly people aged ≥ 65 years in Changshu city for developing immunization strategies on pneumonia prevention in the e
Externí odkaz:
https://doaj.org/article/fa7fb5b90fd44177b58152d250a5d8b3
Autor:
Jiaming SHEN, Xiaofei LIU, Lili HUANG, Yunzhen TAO, Benfeng ZHENG, Genming ZHAO, Jianmei TIAN, Lin LUAN, Xuejun SHAO, Tao ZHANG
Publikováno v:
Zhongguo gonggong weisheng, Vol 39, Iss 11, Pp 1430-1437 (2023)
ObjectiveTo assess the effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPV23) against Streptococcus pneumonia (Spn)-associated respiratory tract infection in children with a test-negative design study. MethodsWe recruited totally 3 33
Externí odkaz:
https://doaj.org/article/049555c5689840548fb5d1c4651e5001
Autor:
Zhongkui Zhu, Jianwen Sun, Yan Xie, Xi Lu, Wanqin Tang, Yanwei Zhao, Lu Shen, Huaxian Liu, Yang Yu, Siliang Zhou, Liqun Huo, Peng Jiao, Xiaoli Jiang
Publikováno v:
Vaccines, Vol 12, Iss 8, p 935 (2024)
The inactivated quadrivalent influenza vaccine (IIV4) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) have been administered for years and could be administered concomitantly if necessary. However, the immunogenicity and safety of the
Externí odkaz:
https://doaj.org/article/dd95b962e4d54fe495bc634dab4a6350
Autor:
Thundon Ngamprasertchai, Chayanis Kositamongkol, Saranath Lawpoolsri, Pinyo Rattanaumpawan, Viravarn Luvira, Piriyaporn Chongtrakool, Jaranit Kaewkungwal, Kulkanya Chokephaibulkit, Pochamana Phisalprapa
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionThis study aims to assess the economic impact of introducing the 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) to Thai older adult aged ≥ 65 years who are healthy or with chr
Externí odkaz:
https://doaj.org/article/dfc96d0a1b934791941f217b39f67adc
Autor:
M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. V. Cherkasova, Zh. G. Verizhnikova, T. V. Korotaeva
Publikováno v:
Антибиотики и Химиотерапия, Vol 67, Iss 1-2, Pp 39-44 (2022)
Background. Immunosuppressive drugs are widely used for the treatment of patients with spondyloarthritis (SpA) to effectively control the activity of the disease. At the same time, the use of these drugs is associated with an increased risk of devel
Externí odkaz:
https://doaj.org/article/67a2b872c9ac45d1af9d3bf26a274eb0
Autor:
Melina Gade Sikjær, Andreas Arnholdt Pedersen, Mari Stenvold Wik, Synne Smith Stensholt, Ole Hilberg, Anders Løkke
Publikováno v:
European Clinical Respiratory Journal, Vol 10, Iss 1 (2023)
ABSTRACTBackground: Invasive pneumococcal disease (IPD) is a major cause of morbidity and mortality globally. However, the literature on the vaccine effectiveness (VE) of 23-valent polysaccharide vaccine (PPV23) and 13-valent conjugated vaccine (PCV1
Externí odkaz:
https://doaj.org/article/2e54a6452d6148eca04aa731ddf5f96d